Bruder Healthcare names Steven Fusco national account director

News
Article

According to the company, Steven Fusco will focus on Bruder Healthcare and Hilco Vision product portfolios.

Fusco has experience building revenue growth and commercial success in the eyecare industry. (Image courtesy of Adobe Stock)

Fusco has experience building revenue growth and commercial success in the eyecare industry. (Image courtesy of Adobe Stock)

Bruder Healthcare announced today of Steven Fusco to its team as the national account director.

In the new role, Fusco will develop initiatives, foster partnerships, and accelerate growth opportunities to expand the company's reach and impact within the eye care sector.

According to a news release, Fusco has experience building revenue growth and commercial success in the eyecare industry. Prior to joining Bruder Healthcare, he served as the senior director of Business Development at Lexitas, an ophthalmic product development company and co-founder of MYZE, an eye care patient engagement platform. He held sales management positions with Santen, an eye care pharmaceutical company, and Eyevance, an ophthalmic products firm later acquired by Santen. Fusco's experience also includes sales and business development roles for medical lab company Quest Diagnostics.

"Steven’s eyecare industry experience combined with his ability to drive growth and innovation align perfectly with our company's mission and message, where we encourage doctors and patients alike to “Open Your Eyes to Bruder”, Brent Jones, general manager of Bruder Healthcare and Global Head of Dry Eye at Hilco Vision, said in the news release.

Bruder Healthcare designs and markets therapeutic and ophthalmic products to healthcare professionals and consumers worldwide, including a moist heat eye compress. Its product line is focused on issues of muscle pain, dry eye, and other ocular conditions.

Hilco Vision is a global eyewear and eye care company that delivers comprehensive solutions to customers.

Recent Videos
1 KOL is featured in this series.
1 KOL is featured in this series.
1 KOL is featured in this series.
1 KOL is featured in this series.
© 2024 MJH Life Sciences

All rights reserved.